Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

101.66 +0.98 (+0.97%)
Official Closing Price Updated: 7:00 PM EDT, Jul 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
56 57 Next >
News headline image
Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades' ↗
Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Management. 
Via Benzinga
News headline image
Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts. ↗
These stocks pay above-average yields, and their dividend income could rise higher in the future. 
Via The Motley Fool
News headline image
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108? ↗
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver. 
Via The Motley Fool
News headline image
3 Stocks Retirees Should Absolutely Love ↗
All of these stocks can provide steady income to retired investors. 
Via The Motley Fool
News headline image
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Chips, Glorious Chips! ↗
Someone's gotta make 'em, and someone's gotta buy 'em. 
Via The Motley Fool
News headline image
3 Dividend Growth Stocks to Buy Hand Over Fist in August ↗
There are blue-chip bargains paying large and growing dividends in the healthcare space. 
Via The Motley Fool
News headline image
Large Cap Biopharma And Healthcare, A Port In A Storm ↗
Healthcare and biopharma show nice gains in a volatile week. 
Via Talk Markets
News headline image
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever. ↗
Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts. 
Via The Motley Fool
News headline image
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off ↗
Dividend stocks are great; cheap dividend stocks are better. 
Via The Motley Fool
News headline image
Abbott Laboratories's Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
Peering Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
News headline image
Behind the Scenes of Abbott Laboratories's Latest Options Trends ↗
 
Via Benzinga
News headline image
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott ↗
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users. 
Via Investor's Business Daily
News headline image
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth ↗
Abbott Laboratories' growth rate may look comparable to Johnson & Johnson's, but in the long run it could become much higher. 
Via The Motley Fool
News headline image
7 Leading MedTech Stocks for Next-Gen Health Solutions ↗
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. 
Via InvestorPlace
News headline image
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow' ↗
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut. 
Via Benzinga
Topics Economy
News headline image
Healthcare Stocks Are Coming On Strong In July Led By Biotech ↗
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
News headline image
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today? ↗
NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem. 
Via InvestorPlace
News headline image
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today? ↗
Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report. 
Via InvestorPlace
News headline image
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know. ↗
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage. 
Via InvestorPlace
News headline image
3 High-Yield Dividend Stocks That Are Looking Super Hot ↗
Discover high-yield dividend stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential. 
Via InvestorPlace
News headline image
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap' ↗
Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-day Federal Open Market Committee meeting starting Tuesday, and Friday’s... 
Via Benzinga
News headline image
Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula ↗
This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts. 
Via Benzinga
Topics Lawsuit
News headline image
Is Beaten-Down Dexcom Stock a Buy on the Dip? ↗
The market may have overreacted to a disappointing earnings report. 
Via The Motley Fool
News headline image
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On? ↗
Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today. 
Via InvestorPlace
News headline image
Better Buy: Abbott Laboratories vs. Intuitive Surgical ↗
The medical technology business has been good for both companies, but which is right for your portfolio? 
Via The Motley Fool
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.